摘要:目的观察晚期肺鳞癌给予树突状细胞(DC)/细胞因子诱导的杀伤细胞(CIK)联合吉西他滨+顺铂(GP)治疗的临床效果。方法选取我院晚期肺鳞癌患者62例,随机分为两个组,对照组(单纯GP治疗)、观察组(联合DC/CIK治疗)各31例,观察临床疗效、生存时间、毒副作用。结果观察组治疗有效27例(87.1%),高于对照组的20例(64.5%);不良反应发生(25.8%)低于对照组(54.8%)(P〈0.05)。结论 DC/CIK联合GP方案在肺鳞癌患者中疗效确切,化疗联合DC/CIK能够提高疾病控制率,延长患者的生存时间,且不良反应较少。
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
Journal of Hydrodynamics Applied Mathematics and Mechanics Nuclear Science and Techniques Applied Geophysics Journal of Genetics and Genomics Advances in Atmospheric Sciences Journal of Systems Science and Complexity Control Theory and Technology Journal of Computer Science and Technology Applied Mathematics:A Journal of Chinese Universities The Journal of China Universities of Posts and Telecommunications